Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix

Modern Pathology

Volumn 11, Issue 1, 1998, Pages 11-18

  Ferguson, Amy W ^a   Svoboda Newman, Suzette M ^a   Frank, Thomas S ^a,b  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b Myriad Genetic Laboratories   (United States)

Author keywords

Adenocarcinoma; Cervix; Human papillomavirus; Ki ras; Loss of heterozygosity; p53

Indexed keywords

GENE PRODUCT; PARAFFIN; PROTEIN P53; TUMOR MARKER;

ALLELE; ARTICLE; GENE DELETION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; BASE SEQUENCE; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; DNA, VIRAL; FEMALE; GENES, RAS; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0031976270     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina, and vulva. In: Rosai J, editor. Atlas of tumor pathology. Washington, D.C.: Armed Forces Institute of Pathology; 1992. p. 83-8.
2. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
3. Hruban RH, van der Riet P, Erozan YS, Sidransky D. Molecular biology and the early detection of carcinoma of the bladder: the case of Hubert H. Humphrey. N Engl J Med 1994;18:1276-8.
4. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
5. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991;10:4129-35.
6. Wilczynski SP, Bergen S, Walker J, Liao S-Y, Pearlman LF. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral subtypes. Hum Pathol 1988;19:697-704.
7. Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, et al. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 1993;72:1272-80.
8. Smotkin D, Berek JS, Fu YS, Hacker NF, Major FI, Wettstein FO. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 1986;68:241-4.
9. Duggan MA, Benoit JL, McGregor SE, Nation JG, Inoue M, Stuart GCE. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization. Hum Pathol 1993;24:121-5.
10. Johnson TL, Kim W-S, Plieth DA, Sarkar FH. Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992;5: 35-40.
11. Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol 1989;35: 345-8.
12. Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs LB, et al. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res 1988;48:993-8.
13. Leminen A, Paavonen J, Vesterinen E, Wahlström T, Rantala I, Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991;95:647-52.
14. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159: 293-6.
15. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. Human papillomavirus type 18 associates with more advanced cervical neoplasia than papillomavirus type 16. Hum Pathol 1993;24:423-37.
16. Kaelbling M, Burk RD, Atkin NB, Johnson AB, Klinger HP. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 1992;340: 140-2.
17. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human papillomavirus-negative tumours. Lancet 1992;339:1070-3.
18. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 1991;51:2979-84.
19. Frank TS, Bartos RE, Haefner HK, Roberts JK, Wilson MD, Hubbell GP. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma. Mod Pathol 1994;7:3-8.
20. Eccles DM, Brett L, Lessells A, Gruber L, Lane D, Steel CM, et al. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer 1992;65:40-4.
21. Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC. p53 mutations in cervical carcinogenesis: low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994;69:732-7.
22. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. Allelotype of human ovarian cancer. Cancer Res 1991;51:5118-22.
23. Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 1993;53:3382-5.
24. Phillips N, Ziegler M, Saha B, Xynos F. Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 1993;54: 85-91.
25. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991;139:777-85.
26. Scully RE, Young RH. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathologic analysis of 16 cases. Int J Gynecol Pathol 1988;7: 99-111.
27. Nishida T, Ushijima K, Oda T, Sugiyama T, Tsuji Y, Imaishi K, et al. Minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix associated with mucinous ovarian carcinoma. Kurume Med J 1991;38:265-9.
28. Sasaki H, Nishii H, Takahashi H, Tada A, Furusato M, Terashima Y, et al. Mutation of the Ki-ras proto-oncogene in human endometrial hyperplasia and carcinoma. Cancer Res 1993;53:1906-10.
29. Caduff RF, Johnston CM, Frank TS. Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Am J Pathol 1995;146:182-8.
30. Fujino T, Risinger JI, Collins NK, Liu F, Nishii H, Takahashi H, et al. Allelotype of endometrial carcinoma. Cancer Res 1994;54:4294-8.
31. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors. Hum Pathol 1995;26:1268-74.
32. Bur ME, Perlman C, Edelmann L, Fey E, Rose PG. p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 1992;98:81-7.
33. Frank TS, Svoboda-Newman SM, Hsi ED. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diagn Mol Pathol 1996;5: 220-4.
34. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter-Schegget J, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-84.
35. Frank TS, Cook SM, Del Buono EA, Wilson MD. A simplified method for detecting cytomegalovirus by polymerase chain reaction from histologic sections of small biopsies. Mod Pathol 1992;5:449-54.
36. Banks L, Matlashewski G, Crawford L. Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986;159: 529-34.
37. Kerns BJ, Jordan PA, Moore MH, Humphrey PA, Berchuck A, Kohler MF, et al. p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem 1992;40:1047-51.
38. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52:1974-80.
39. Fukushima M, Shimano S, Yamakawa Y, Yamaguchi T, Sawada Y, Hashimoto M, et al. The detection of human papillomavirus (HPV) in a case of minimal deviation adenocarcinoma of the uterine cervix (adenoma malignum) using in situ hybridization. Jpn J Clin Oncol 1990;20:407-12.
40. Matseoane S, Moscovic E, Williams S, Huang J-C. Mucinous neoplasm in the cervix associated with a mucinous neoplasm in the ovary and concurrent bilateral sex cord tumors with annular tubules: immunohistochemical study. Gynecol Oncol 1991;43:300-4.
41. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 1990;50:6139-45.
42. Allan RN, Pease P, Ibbotson JP. Clustering of Crohn's disease in a Cotswold village. Q J Med 1986;59:473-8.
43. Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajuer SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996;148:1671-8.
44. Bethwaite PB, Koreth J, Herrington CS, McGee JO'D. Loss of heterozygosity occurs at the D11S29 locus on chromosome 1q23 in invasive cervical carcinoma. Br J Cancer 1995;71: 814-8.
45. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, et al. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-24. Proc Natl Acad Sci U S A 1994;91:6953-7.
46. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989;49:3598-601.
47. Caduff RF, Svoboda-Newman SM, Bartos RE, Ferguson AW, Frank TS. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma. Am J Surg Pathol. In press 1998.